Request for Information - Project NextGen: Potential Market Shaping Strategies for Vaccine Development
Closed Special Notice Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 75A50123R00003
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Washington, District of Columbia 20024, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response published a Request for Information on potential market shaping strategies for vaccine development. The primary intent of the RFI is to explore additional ways in which Project NextGen could better ensure that next generation COVID-19 vaccine technologies ultimately benefit people and bolster preparedness against future variants.
The RFI seeks input on establishing objectives for threshold and optimal vaccine target product profiles addressing characteristics such as safety, immunogenicity, efficacy, durability of protection, manufacturing, and pricing. Respondents are asked to provide feedback on measuring products' ability to meet objectives, prize award amounts and structures, and potential collaboration opportunities. All responses must be submitted in PDF format to the named contracting officer by August 10, 2023. No set-aside is designated and eligibility is open to all potential sources.
Notice text
The primary intent of this Request for Information (RFI) is to explore additional ways in which Project NextGen could better ensure that next generation COVID-19 vaccine technologies ultimately benefit people and bolster preparedness against future variants, by reducing technological, regulatory, and market risk.
Please see the attachment to access this RFI in its entirety.
All responses are due by no later than August 10, 2023 at 5:00 PM EST.
Files
| File | Type | Posted |
|---|---|---|
| Pull Incentives for Vx Development RFI 7.6.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Award Notice: Intranasal Nalmefene Drug-Device Combination | Award Notice | |
| RFP - Intranasal Nalmefene Drug-Device Combination | Solicitation | |
| Pre-Solicitation Notice: Intranasal Nalmefene Drug-Device Combination | Pre-Solicitation | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Information – Prophylactic Platform for Medical Countermeasures | ACC Aberdeen Proving Ground | No set-aside | |
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity